ARTICLE | Company News
Koronis infectious news
May 10, 2010 7:00 AM UTC
Koronis hired Rondaxe Enterprises LLC to secure a partner to develop and commercialize KP-1461. The oral prodrug of KP-1212, a small molecule nucleoside analog that works through Viral Decay Accelera...